Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Hong

Showing results (171-180 of 442) with videos related to

Pageof 45
Sort By:
Targeted Oncology|June 4, 2025
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid TumorsLillian L Siu, David S Hong, Wolf-Dietrich Döcke, et al.
Journal of Neurosurgery. Pediatrics|October 29, 2021
Incorporating patient-centered quality-of-life measures for outcome assessment after Chiari malformation type I decompression in a pediatric population: a pilot studySolomiia Savchuk, Michael C Jin, Stephanie Choi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2012
Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosisJose Luis Lopez Guerra, Daniel Gomez, Yan Zhuang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2012
BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competencyDavid S Hong, Luis Vence, Gerald Falchook, et al.
Personalized Medicine in Psychiatry|May 31, 2022
Identification of biotypes in Attention-Deficit/Hyperactivity Disorder, a report from a randomized, controlled trialJohn E Leikauf, Kristi R Griffiths, Manish Saggar, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2023
Open RT Structures: A Solution for TG-263 AccessibilityBrian M Anderson, Laura Padilla, Jeffrey M Ryckman, et al.
Journal of Neurosurgery. Pediatrics|August 1, 2025
Comprehensive pediatric neurosurgical implant checklist to maintain low implant infection rates: lessons on compliance and institutional cultureArokoruba O Cheetham-West, Kevin K Kumar, Jenna F Kruger, et al.
Investigational New Drugs|August 3, 2013
Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignanciesGerald S Falchook, Siqing Fu, Aung Naing, et al.
Molecular Cancer Therapeutics|August 22, 2013
Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutationsJennifer J Wheler, Apostolia M Tsimberidou, Gerald S Falchook, et al.
Nature Communications|August 5, 2017
Molecular characterization of breast cancer CTCs associated with brain metastasisDebasish Boral, Monika Vishnoi, Haowen N Liu, et al.
Pageof 45

Showing results (171-180 of 442) with videos related to

Sort By:
Pageof 45
Targeted Oncology|June 4, 2025
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid TumorsLillian L Siu, David S Hong, Wolf-Dietrich Döcke, et al.
Journal of Neurosurgery. Pediatrics|October 29, 2021
Incorporating patient-centered quality-of-life measures for outcome assessment after Chiari malformation type I decompression in a pediatric population: a pilot studySolomiia Savchuk, Michael C Jin, Stephanie Choi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2012
Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosisJose Luis Lopez Guerra, Daniel Gomez, Yan Zhuang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2012
BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competencyDavid S Hong, Luis Vence, Gerald Falchook, et al.
Personalized Medicine in Psychiatry|May 31, 2022
Identification of biotypes in Attention-Deficit/Hyperactivity Disorder, a report from a randomized, controlled trialJohn E Leikauf, Kristi R Griffiths, Manish Saggar, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2023
Open RT Structures: A Solution for TG-263 AccessibilityBrian M Anderson, Laura Padilla, Jeffrey M Ryckman, et al.
Journal of Neurosurgery. Pediatrics|August 1, 2025
Comprehensive pediatric neurosurgical implant checklist to maintain low implant infection rates: lessons on compliance and institutional cultureArokoruba O Cheetham-West, Kevin K Kumar, Jenna F Kruger, et al.
Investigational New Drugs|August 3, 2013
Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignanciesGerald S Falchook, Siqing Fu, Aung Naing, et al.
Molecular Cancer Therapeutics|August 22, 2013
Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutationsJennifer J Wheler, Apostolia M Tsimberidou, Gerald S Falchook, et al.
Nature Communications|August 5, 2017
Molecular characterization of breast cancer CTCs associated with brain metastasisDebasish Boral, Monika Vishnoi, Haowen N Liu, et al.
Pageof 45